By Professor Kerry-Anne Rye

Journal articles

Glaros EN; Kim WS; Rye K; Shayman J; Garner B, 2008, 'Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice', Journal of Lipid Research, 49, pp. 1677 - 1681, http://dx.doi.org/10.1194/jlr.E800005-JLR200

Patel S; Drew B; Nakhla S; Barter P; Rye K-A; Kingwell B; Celermajer D, 2008, 'The Anti-inflammatory Capacity of Human High Density Lipoproteins (HDL) is Significantly Enhanced after Infusion of Reconstituted HDL “In Vivo”', Heart, Lung and Circulation, 17, pp. S2 - S3, http://dx.doi.org/10.1016/j.hlc.2008.05.003

Ng TWK; Watts GF; Barrett PHR; Rye KA; Chan DC, 2007, 'Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: Associations with changes in plasma retinol-binding protein-4 and adiponectin levels', Diabetes Care, 30, pp. 2945 - 2950, http://dx.doi.org/10.2337/dc07-0768

Barter PJ; Puranik R; Rye KA, 2007, 'New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease', Current Cardiology Reports, 9, pp. 493 - 498, http://dx.doi.org/10.1007/BF02938394

Patel S; Drew B; Duffy S; Nahkla S; Rye K-A; Barter P; Celermajer D; Kingwell B, 2007, 'Abstract 1047: Infusion of Reconstituted High Density Lipoproteins Into Humans Enhances the In Vitro Anti-Inflammatory Capacity of the High Density Lipoprotein Fraction.', Circulation, 116, http://dx.doi.org/10.1161/circ.116.suppl_16.ii_209-a

Skropeta D; Settasatian C; McMahon MR; Shearston K; Caiazza D; McGrath KC; Jin W; Rader DJ; Barter PJ; Rye KA, 2007, 'N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins', Journal of Lipid Research, 48, pp. 2047 - 2057, http://dx.doi.org/10.1194/jlr.M700248-JLR200

Matsuo Y; Miura SI; Kawamura A; Uehara Y; Rye KA; Saku K, 2007, 'Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation', Atherosclerosis, 194, pp. 159 - 168, http://dx.doi.org/10.1016/j.atherosclerosis.2006.10.020

Ooi EMM; Chan DC; Rye KA; Watts GF, 2007, 'Differences in plasma PLTP activity assays: Constant or random error? [2]', Clinical Endocrinology, 67, pp. 317, http://dx.doi.org/10.1111/j.1365-2265.2007.02867.x

Zhang B; Uehara Y; Hida S; Miura SI; Rainwater DL; Segawa M; Kumagai K; Rye KA; Saku K, 2007, 'Effects of reconstituted HDL on charge-based LDL subfractions as characterized by capillary isotachophoresis', Journal of Lipid Research, 48, pp. 1175 - 1189, http://dx.doi.org/10.1194/jlr.M600227-JLR200

Sumi M; Sata M; Miura SI; Rye KA; Toya N; Kanaoka Y; Yanaga K; Ohki T; Saku K; Nagai R, 2007, 'Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis', Arteriosclerosis, Thrombosis, and Vascular Biology, 27, pp. 813 - 818, http://dx.doi.org/10.1161/01.ATV.0000259299.38843.64

Nobecourt E; Davies MJ; Brown BE; Curtiss LK; Bonnet DJ; Charlton F; Januszewski AS; Jenkins AJ; Barter PJ; Rye KA, 2007, 'The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase', Diabetologia, 50, pp. 643 - 653, http://dx.doi.org/10.1007/s00125-006-0574-z

Watts GF; Ji J; Chan DC; Ooi EMM; Johnson AG; Rye KA; Barrett PHR, 2007, 'Erratum: Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome (Clinical Science (2006) 111, (193-199))', Clinical Science, 112, pp. 625, http://dx.doi.org/10.1042/cs1120625

Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye K; Stocker R; Jessup W; Garner B, 2007, 'Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration', Biochemical Pharmacology, 73, pp. 1340 - 1346

Ng TWK; Watts GF; Barrett PHR; Rye KA; Chan DCF, 2007, 'LB-PO-867 EFFECT OF WEIGHT LOSS ON LDL AND HDL METABOLISM: INDEPENDENT REGULATORY ROLES OF ADIPONECTIN BUT NOT RETINOL-BINDING PROTEIN-4', Atherosclerosis Supplements, 8, pp. 232 - 232, http://dx.doi.org/10.1016/s1567-5688(07)71883-4

Kim WS; Rahmanto A; Kamili A; Rye K; Guillemin GJ; Gelissen I; Jessup W; Hill A; Garner B, 2007, 'Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation', The Journal of Biological Chemistry, 282, pp. 2851 - 2861

Patel S; Barter PJ; Celermajer DS; Rye K-A, 2007, 'The Fate of Reconstituted High Density Lipoproteins in Vivo', Heart, Lung and Circulation, 16, pp. S167 - S167, http://dx.doi.org/10.1016/j.hlc.2007.06.416

Patel S; Puranik R; Nakhla S; Lundman P; Rye K; Barter PJ; Nicholls SJ; Celermajer DS, 2007, 'Transient Triglyceridaemia Reduces the Anti-inflammatory Properties of High-density Lipoprotein', Heart, Lung and Circulation, 16, pp. S167 - S168, http://dx.doi.org/10.1016/j.hlc.2007.06.417

Ooi EMM; Watts GF; Ji J; Rye KA; Johnson AG; Chan DC; Barrett PHR, 2006, 'Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo', Clinical Endocrinology, 65, pp. 752 - 759, http://dx.doi.org/10.1111/j.1365-2265.2006.02662.x

Zhang B; Katafuchi R; Arishima H; Matsunaga A; Rye KA; Saku K, 2006, 'Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis', Clinica Chimica Acta, 373, pp. 55 - 61, http://dx.doi.org/10.1016/j.cca.2006.04.026

Zhang B; Miura SI; Fan P; Kumagai K; Takeuchi K; Uehara Y; McMahon M; Rye KA; Saku K, 2006, 'ApoA-I/phosphatidylcholine discs remodels fast-migrating HDL into slow-migrating HDL as characterized by capillary isotachophoresis', Atherosclerosis, 188, pp. 95 - 101, http://dx.doi.org/10.1016/j.atherosclerosis.2005.10.032

Barter PJ; Rye KA, 2006, 'Homocysteine and cardiovascular disease: Is HDL the link?', Circulation Research, 99, pp. 565 - 566, http://dx.doi.org/10.1161/01.RES.0000243583.39694.1f

Gotto AM; Barter PJ; Rye KA, 2006, 'Over-the-counter statins are worth considering in primary prevention of cardiovascular disease', Circulation, 114, pp. 1310 - 1314, http://dx.doi.org/10.1161/CIRCULATIONAHA.105.552257

Watts GF; Ji J; Chan DC; Ooi EMM; Johnson AG; Rye KA; Barrett PHR, 2006, 'Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome', Clinical Science, 111, pp. 193 - 199, http://dx.doi.org/10.1042/CS20060072

Barter PJ; Rye KA; Gotto AM, 2006, 'The argument against the appropriateness of over-the-counter statins', Circulation, 114, pp. 1315 - 1320, http://dx.doi.org/10.1161/CIRCULATIONAHA.105.604991

Nicholls SJ; Lundman P; Harmer JA; Cutri B; Griffiths KA; Rye KA; Barter PJ; Celermajer DS, 2006, 'Consumption of Saturated Fat Impairs the Anti-Inflammatory Properties of High-Density Lipoproteins and Endothelial Function', Journal of the American College of Cardiology, 48, pp. 715 - 720, http://dx.doi.org/10.1016/j.jacc.2006.04.080

Barter PJ; Rye KA, 2006, 'Relationship between the concentration and antiatherogenic activity of high-density lipoproteins', Current Opinion in Lipidology, 17, pp. 399 - 403, http://dx.doi.org/10.1097/01.mol.0000236365.40969.af

Barter P; Rye KA, 2006, 'Are we lowering LDL cholesterol sufficiently?', Nature Clinical Practice Cardiovascular Medicine, 3, pp. 290 - 291, http://dx.doi.org/10.1038/ncpcardio0555

Ooi EMM; Watts GF; Ji J; Johnson AG; Rye KA; Chan DC; Barrett PHR, 2006, 'Balancing feedback and lipoprotein transport in the metabolic syndrome', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 577 - 577, http://dx.doi.org/10.1016/S1567-5688(06)82337-8

Brown BE; Nobecourt E; Rye K-A; Davies MJ, 2006, 'Glycation of lipid-free apolipoprotein A-I impairs cholesterol efflux from macrophages', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 541 - 541, http://dx.doi.org/10.1016/S1567-5688(06)82177-X

Ji J; Watts GF; Johnson AG; Chan DC; Ooi EMM; Rye KA; Serone AP; Barrett PHR, 2006, 'High-density lipoprotien transport in the metabolic syndrome: Application of a new model for HDL particle kinetics', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 534 - 534, http://dx.doi.org/10.1016/S1567-5688(06)82145-8

Ji J; Barrett PHR; Johnson AG; Chan DC; Serone AP; Rye KA; Watts GF, 2006, 'Lipid transfer proteins and apolipoprotein B-100 metabolism in the metabolic syndrome treated with fenofibrate', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 370 - 370, http://dx.doi.org/10.1016/S1567-5688(06)81465-0

Miura S; Kiya Y; Imaizumi S; Zhang B; Matsuo Y; Uehara Y; Rye KA; Saku K, 2006, 'Peiotropic action of HDL and HDL therapy', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 561 - 561, http://dx.doi.org/10.1016/S1567-5688(06)82268-3

Imaizumi S; Miura S; Kiya Y; Zhang B; Uehara Y; Rye KA; Saku K, 2006, 'Pharmacological intervention using reconstituted high-density lipoprotein changes the lipid profile in spontaneously hypersensitive rats', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 562 - 562, http://dx.doi.org/10.1016/S1567-5688(06)82271-3

Ooi EMM; Watts GF; Ji J; Rye KA; Johnson AG; Chan DC; Barrett PHR, 2006, 'Role of plasma phospholipid transfer protein activity in determining HDL kinetics in vivo', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 535 - 535, http://dx.doi.org/10.1016/S1567-5688(06)82152-5

Tso C; Martinic G; Fan WH; Rogers C; Rye KA; Barter PJ, 2006, 'High-density lipoproteins enhance progenitor-mediated endothelium repair in mice', Arteriosclerosis, Thrombosis, and Vascular Biology, 26, pp. 1144 - 1149, http://dx.doi.org/10.1161/01.ATV.0000216600.37436.cf

Rye KA; Bright R; Psaltis M; Barter PJ, 2006, 'Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E', Journal of Lipid Research, 47, pp. 1025 - 1036, http://dx.doi.org/10.1194/jlr.M500525-JLR200

Kee P; Caiazza D; Rye KA; Barrett PHR; Morehouse LA; Barter PJ, 2006, 'Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: In vivo studies in rabbits', Arteriosclerosis, Thrombosis, and Vascular Biology, 26, pp. 884 - 890, http://dx.doi.org/10.1161/01.ATV.0000201064.89581.35

Barter PJ; Rye KA, 2006, 'Cardioprotective properties of fibrates: Which fibrate, which patients, what mechanism?', Circulation, 113, pp. 1553 - 1555, http://dx.doi.org/10.1161/CIRCULATIONAHA.105.620450

Ji J; Watts GF; Johnson AG; Chan DC; Ooi EMM; Rye KA; Serone AP; Barrett PHR, 2006, 'High-density lipoprotein (HDL) transport in the metabolic syndrome: Application of a new model for HDL particle kinetics', Journal of Clinical Endocrinology and Metabolism, 91, pp. 973 - 979, http://dx.doi.org/10.1210/jc.2005-1895

Hime NJ; Drew KJ; Wee K; Barter PJ; Rye KA, 2006, 'Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit', Journal of Lipid Research, 47, pp. 115 - 122, http://dx.doi.org/10.1194/jlr.M500284-JLR200

Curtiss LK; Valenta DT; Hime NJ; Rye KA, 2006, 'What is so special about apolipoprotein AI in reverse cholesterol transport?', Arteriosclerosis, Thrombosis, and Vascular Biology, 26, pp. 12 - 19, http://dx.doi.org/10.1161/01.ATV.0000194291.94269.5a

Jessup W; Gelissen I; Kritharides L; Quinn CM; Kockx M; Brown AJ; Rye K; Harris M; Packianathan M; Cartland SP, 2006, 'ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I', Arteriosclerosis, Thrombosis and Vascular Biology, 26, pp. 534 - 540

Gelissen I; Rye K-A; Quinn C; Brown A; Kockx M; Cartland S; Kritharides L; Jessup W, 2006, 'Concerted action of ABCA1 and ABCG1 in cell cholesterol export', Vascular Pharmacology, 45, pp. e23 - e23, http://dx.doi.org/10.1016/j.vph.2006.08.107

Rentero C; Tebar F; de Muga S; Cubells L; de Diego M; Hayes T; Hughes WE; Pol A; Rye K; Enrich C; Grewal T; Wood P; Evans R, 2006, 'Inhibition of H-Ras and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells', Cellular Signalling, 18, pp. 1006 - 1016

Nobecourt E; Davies M; Zeng J; Rye K-A, 2006, 'Mo-P1:113 Inhibition of apolipoprotein A-I glycation restores its ability to activate lecithin: Cholesterol acyl transferase', Atherosclerosis Supplements, 7, pp. 71 - 71, http://dx.doi.org/10.1016/s1567-5688(06)80248-5

Nobecourt E; Puranik RAJ; Bao S; Davies M; Barter P; Rye K-A, 2006, 'Mo-P1:114 Evidence that glycation of apolipoprotein A-I inhibits the anti-inflammatory properties of HDL in vivo', Atherosclerosis Supplements, 7, pp. 71 - 71, http://dx.doi.org/10.1016/s1567-5688(06)80249-7

Matsuo Y; Miura S; Kiya Y; Uehara Y; Imaizumi S; Rye KA; Saku K, 2006, 'Th-P15:197 Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation', Atherosclerosis Supplements, 7, pp. 536 - 536, http://dx.doi.org/10.1016/s1567-5688(06)82156-2

Heather AK; McGrath KC-Y; Puranik R; Tsatralis T; Celermajer D; Barter P; Rye K, 2006, 'Tu-P7:218 HDL exerts novel anti-inflammatory effects on endothelial cells via the suppression on NFKB', Atherosclerosis Supplements, 7, pp. 232 - 232, http://dx.doi.org/10.1016/s1567-5688(06)80922-0

Rye K-A; Puranik R; Nobecourt E; Bao S; Nicholls SJ; Barter PJ, 2006, 'Tu-W16:1 HDL and the inhibition of inflammation in vivo', Atherosclerosis Supplements, 7, pp. 152 - 152, http://dx.doi.org/10.1016/s1567-5688(06)80597-0

Barrett PHR; Kee P; Caiazza D; Rye KA; Morehouse LA; Barter PJ, 2006, 'We-W38:5 Effect of inhibiting cholesteryl ester transfer protein on the kinetics of HDL cholesteryl ester transport in plasma: In vivo studies in rabbits', Atherosclerosis Supplements, 7, pp. 322 - 322, http://dx.doi.org/10.1016/s1567-5688(06)81285-7

Back to profile page